Therapeutic Hypothermia in Acute Ischemic Stroke-a Systematic Review and Meta-Analysis.

Ischemic stroke Meta-analysis Selective cooling Systemic cooling Therapeutic hypothermia

Journal

Current neurology and neuroscience reports
ISSN: 1534-6293
Titre abrégé: Curr Neurol Neurosci Rep
Pays: United States
ID NLM: 100931790

Informations de publication

Date de publication:
05 05 2020
Historique:
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 15 12 2020
Statut: epublish

Résumé

Therapeutic hypothermia (TH) in stroke demonstrates robust neuroprotection in animals but clinical applications remain controversial. We assessed current literature on the efficacy of TH in ischemic stroke. We conducted a meta-analysis comparing TH versus controls in studies published until June 2019. Controlled studies reporting on ≥ 10 adults with acute ischemic stroke were included. Primary outcome was functional independence (modified Rankin Scale [mRS] ≤ 2). Twelve studies (n = 351 TH, n = 427 controls) were included. Functional independence did not differ between groups (RR 1.17, 95% CI 0.93-1.46, random-effects p = 0.2). Five studies reported individual mRS outcomes and demonstrated a shift toward better outcome with TH (unadjusted cOR 1.57, 95% CI 1.01-2.44, p = 0.05). Overall complications were higher with TH (RR 1.18, 95% CI 1.06-1.32, p < 0.01). We did not observe an overall beneficial effect of TH in this analysis although some studies showed a shift toward better outcome. TH was associated with increased complications.

Identifiants

pubmed: 32372297
doi: 10.1007/s11910-020-01029-3
pii: 10.1007/s11910-020-01029-3
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Auteurs

Andrea M Kuczynski (AM)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Sina Marzoughi (S)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Abdulaziz S Al Sultan (AS)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Frederick Colbourne (F)

Department of Psychology, University of Alberta, Edmonton, AB, Canada.

Bijoy K Menon (BK)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, AB, Canada.

Adriaan C G M van Es (ACGM)

Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.

Aaron L Berez (AL)

Alembic, LLC, Mountain View, CA, 94043, USA.

Mayank Goyal (M)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Radiology, University of Calgary, Calgary, AB, Canada.

Andrew M Demchuk (AM)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, AB, Canada.

Mohammed A Almekhlafi (MA)

Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. mohammed.almekhlafi1@ucalgary.ca.
Department of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, AB, Canada. mohammed.almekhlafi1@ucalgary.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH